Needham & Company Remains Sidelined on SYNNEX Corp. (SNX) Following Mixed 1Q

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Needham & Company Remains Sidelined on SYNNEX Corp. (SNX) Following Mixed 1Q

Synnex (SNX) Results Confirm Underperform Thesis - Raymond James

March 29, 2016 9:01 AM EDT

Raymond James analyst, Brian Alexander, reiterated his Underperform rating as SYNNEX (NYSE: SNX) financial results came in below expectations and financial targets were pushed out.

SNX following below consensus F1Q16 (Feb.) results, sharply lower F2Q (May) guidance, and a pushout of intermediate financial targets. F1Q EPS was in line with consensus estimates of $1.37, but results included a ~$0.06/share... More

After-Hours Stock Movers 03/28: (FL) (DCT) (ALDR) Higher; (ALXA) (GEVO) (PBYI) Lower (more...)

March 28, 2016 6:11 PM EDT

Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) 49.7% LOWER; warns it may shut-down if it is unable to source additional capital.

Gevo, Inc. (Nasdaq: GEVO) 21.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series C units, with each Series C unit consisting of one share of common stock, Series F warrants to purchase a certain number of shares of common stock and Series H warrants to purchase a certain number of... More

SYNNEX Corp. (SNX) Reports In-Line Q1 EPS; Issues Light Q2 Outlook

March 28, 2016 4:14 PM EDT

SYNNEX Corp. (NYSE: SNX) reported Q1 EPS of $1.37, in-line with the analyst estimate of $1.37. Revenue for the quarter came in at $3.13 billion versus the consensus estimate of $3.26 billion.

GUIDANCE:

SYNNEX Corp. sees Q2 2016 EPS of $1.27-$1.33, versus the consensus of... More